Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma
An interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab ...
Apr 24, 2024
0
1